Arnd Wiegmann on Muck Rack

Arnd Wiegmann

Zurich
As seen in: Jornal Extra, MSN, MSN Canada, MSN Singapore, Business Insider, Daily Mail, El País, MSN Australia, MSN UK, Reuters and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arnd

Contact Arnd, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial

|
By Arnd Wiegmann
| The Telegraph (Macon)
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity drug, with more than a quarter of those who received the highest dose achieving at least 30% weight loss.
Open in Who Shared Issue with article?

Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial

|
By Arnd Wiegmann
| Wichita Eagle
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity drug, with more than a quarter of those who received the highest dose achieving at least 30% weight loss.
Open in Who Shared Issue with article?

Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial

|
By Arnd Wiegmann
| San Luis Obispo Tribune
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Arnd Wiegmann Reuters Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity drug, with more than a quarter of those who received the highest dose achieving at least 30% weight loss.
Open in Who Shared Issue with article?
See all 1,102 licensed articles (1,118 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Arnd

Contact Arnd, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified